A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
Written by CannIntelligence || 5th March 2020 || News analysis | Companies | Policy and Politics | Regulation and legislation | Canada Colorado New York North America United States